Bovine Mastitis Market Size to Reach USD 1.84 Billion by 2027; Increasing Investment in R&D of Treatment Options Will Provide Impetus to Market Growth

The global bovine mastitis market size is projected to reach USD 1.84 billion by the end of 2027. Increasing demand for dairy and dairy products will create a huge emphasis on efficient treatment options. According to a report published by Fortune Business Insights, titled “Bovine Mastitis Market Size, Share & COVID-19 Impact Analysis, By Type (Clinical, and Sub-Clinical), By Product (Antibiotics, and Others), By Route of Administration (Intra-mammary, and Systemic), By Therapy (Lactating Period and Dry Period) and Regional Forecast, 2020-2027,” the market was worth USD 1.23 billion in 2019 and will exhibit a CAGR of 5.2% during the forecast period, 2020-2027.

Bovine mastitis is a medical condition in daily cattle, wherein the mammary gland and udder tissue in the cattle inflames. The risks associated with the occurrence of the disease are high accounting to its impact on milk-secreting tissues in the cattle. Increasing research and development activities associated with the treatment of the disease will emerge in favour of the growth of the overall bovine mastitis market in the coming years. The rising dairy applications will create a huge emphasis on the development of efficient treatment options. Accounting to rising emphasis on the development of easy treatment options, several large scale companies are focusing on introducing novel products with the aim of establishing a stronghold in the market. The presence of several large scale companies will constitute an increase in the overall market size. Additionally, rising investment in R&D and initiatives untaken by many animal healthcare organisations in promoting the usage of internal teat sealants to prevent the new mastitis cases at drying off will contribute to the growth of the market in the forthcoming years.

Zoetis Announces Collaboration with CSU for New Research Lab

The report highlights a few of the major strategies adopted by leading companies across the world. Accounting to the increasing demand for dairy and dairy products, several large scale companies are looking to capitalize on this by adopting newer strategies. Many companies are also looking to collaborate with other large scale counterparts, with the bid to acquiring a wider consumer base. In July 2019, Zoetis announced that it has collaborated with the Colorado State University (CSU). This collaboration is aimed at the development of a new research laboratory that will be dedicated for the research and development of target immunotherapies for livestock. This will help ease the risks associated with the disease in cattle and subsequently yield products that are safe to consume for humans as well as other animals. Zoetis’ collaboration with CSU is one of the many large scale collaborations of recent years that have influenced the growth of the overall market.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/bovine-mastitis-market-103482

Focus on Development of Novel Treatment Options will Emerge in Favor of Market Growth

The report encompasses several factors that have contributed to the growth of the global market in recent years. Accounting to the sensitivity and severity associated with the disease on animal as well as human health, several efforts are being taken to develop products that will help minimize these risks at an early stage. The massive investment in the research and development of novel treatment options will have a huge impact on the growth of the overall market in the foreseeable future.

Merck & Co. Inc., Zoetis, and Boehringer Ingelheim are Among the Leading Companies in the Global Market

Accounting to the massive demand for efficient treatment options associated with bovine mastitis, several large scale companies are investing massive sums in the development of novel treatment options. The use of advanced medical concepts and rising R&D activities will not just yield desired products, but will also emerge in favor of the companies in this market. With a strong product portfolio, Boehringer, Zoetis, and Merck & Co, Inc. are a few of the leading companies in the global market.

List of companies profiled in the report:

• Zoetis (New Jersey, U.S.)             
• Merck & Co., Inc. (MSD Animal Health)   (Kenilworth, New Jersey, U.S.)          
• Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany)    
• Bayer AG (Leverkusen, Germany)
• Elanco (Indiana, U.S.)
• Ceva  (Libourne, France)                                                                         
• West Way Health (Galway, Ireland)
• Others

Industry Developments:

• July 2019: Zoetis announced that it has collaborated with the Colorado State University (CSU) to establish a research lab which will explore target new immunotherapies for livestock.

The global market is segmented on the basis of: